Chinese mRNA Covid Booster Stronger Against Omicron Than Sinovac Shot

KONTAN.CO.ID - BEIJING. A Covid-19 vaccine candidate from China's Walvax Biotechnology using mRNA technology triggered a stronger antibody response against the Omicron variant of the coronavirus as a booster dose than Sinovac's shot. Clinical trial data showed.
The result for Walvax's ARCoV candidate, which is yet to be peer reviewed, comes as competition for the Covid booster market intensifies in China, where more than half of the 1,4 billion population have so far received a non-mRNA booster shot.
Ini Artikel Spesial
Agar bisa lanjut membaca sampai tuntas artikel ini, pastikan Anda sudah berlangganan.
Sudah berlangganan? MasukBerlangganan dengan Google
Gratis uji coba 7 hari pertama. Anda dapat menggunakan akun Google sebagai metode pembayaran.
Kontan Digital Premium Access
Business Insight, Epaper Harian + Tabloid, Arsip Epaper 30 Hari
Rp 120.000
Business Insight
Hanya dengan 20rb/bulan Anda bisa mendapatkan berita serta analisis ekonomi bisnis dan investasi pilihan